224 related articles for article (PubMed ID: 22816241)
1. Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer.
Murgić J; Prpić M; Kirac I; Camino-Varela AM; Bolanca A; Kusić Z
Coll Antropol; 2012 Mar; 36(1):325-9. PubMed ID: 22816241
[TBL] [Abstract][Full Text] [Related]
2. Flare-up of dermatomyositis along with recurrence of breast cancer.
Osako T; Ito Y; Morimatsu A; Tada K; Sakurai N; Takahashi S; Akiyama F; Iwase T; Hatake K
Breast J; 2007; 13(2):200-2. PubMed ID: 17319865
[TBL] [Abstract][Full Text] [Related]
3. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease.
Broom RJ; Harvey VJ; Lee KM
Clin Breast Cancer; 2006 Jun; 7(2):162-3. PubMed ID: 16800977
[TBL] [Abstract][Full Text] [Related]
6. A retrospective series of long-term survivors of metastatic breast cancer in complete remission.
Amoroso V; Valcamonico F; Simoncini E; Ardighieri L; Grisanti S; Vassalli L; Marpicati P; Lucini L; Ferrari VD; Rangoni G; Marini G
Oncology; 2005; 68(1):48-51. PubMed ID: 15809519
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
9. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
10. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic vesiculobullous dermatomyositis with synchronic prostate and tongue tumors: case report.
Caratta PR; Mafort T; Pamplona M; Schau B; Estrella RR; Ramos RC
Rev Bras Reumatol; 2011; 51(4):394-6, 407. PubMed ID: 21779715
[TBL] [Abstract][Full Text] [Related]
12. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA
Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987
[TBL] [Abstract][Full Text] [Related]
13. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
16. Surviving metastatic breast cancer for 18 years: a case report and review of the literature.
Bayraktar S; Garcia-Buitrago MT; Hurley E; Gluck S
Breast J; 2011; 17(5):521-4. PubMed ID: 21726350
[TBL] [Abstract][Full Text] [Related]
17. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
[TBL] [Abstract][Full Text] [Related]
18. Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?
Chaturvedi S; McLaren C; Schofield AC; Ogston KN; Sarkar TK; Hutcheon AW; Miller ID; Heys SD
Breast Cancer Res Treat; 2005 Sep; 93(2):151-8. PubMed ID: 16187235
[TBL] [Abstract][Full Text] [Related]
19. [A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy].
Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N
Gan No Rinsho; 1989 Apr; 35(5):581-6. PubMed ID: 2541272
[TBL] [Abstract][Full Text] [Related]
20. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
